Legal Opinion
In Re Gabapentin Patent Litigation
District Court, D. New Jersey
Decided August 27, 2009No. 2:00-mj-04168PublishedCited by 4 opinions
1Opinion of the Court
OPINION
HOCHBERG, District Judge.
This matter comes before the Court upon Plaintiff Warner-Lambert’s Motion to Strike Certain Affirmative Defenses of the Teva, IVAX, and Eon Defendants (Docket #430), pursuant to Fed.R.Civ.P. 12(f). 1 The Court has considered the briefs of the parties, and oral argument held on April 22, 2009. 2
I. Background
Plaintiffs are the drug manufacturers and patent holders for gabapentin, a drug that is used to prevent and limit epileptic seizures. Gabapentin has been marketed under the tradename Neurontin since 1994. 3 Defendants are generic drug manufacturers seeking to…
2Cases cited36 opinions
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Blonder-Tongue Laboratories, Inc. v. University of Illinois FoundationSupreme Court of the United States · 1971
- Precision Instrument Manufacturing Co. v. Automotive Maintenance MacHinery Co.Supreme Court of the United States · 1945
- State Oil Co. v. KhanSupreme Court of the United States · 1997
- Keystone Driller Co. v. General Excavator Co.Supreme Court of the United States · 1933
31 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Deutsche Bank National Trust Co. v. GabrielMassachusetts Appeals Court · 2012
- Otsuka Pharmaceutical Co. v. Apotex Corp.District Court, D. New Jersey · 2015
- CONOPCO, INC. v. WBM, LLCDistrict Court, D. New Jersey · 2023